Literature DB >> 11983666

Anesthetic management of a parturient with Ehlers Danlos syndrome type IV.

Nicola Campbell1, Ola P Rosaeg.   

Abstract

PURPOSE: To describe the anesthetic management of a parturient with Ehlers Danlos syndrome (EDS) type IV. CLINICAL FEATURES: A 29-yr-old pregnant woman with EDS type IV was seen in the Obstetric Anesthesia Pre-assessment Clinic at 30 weeks gestation. She had a history of vertebral artery dissection, resulting in a transient neurological deficit at 22 yr of age. She had a normal vaginal delivery with continuous epidural analgesia for the delivery of her first child at 27 yr of age, before the diagnosis of EDS was made. Recent fibroblast culture demonstrated the production of abnormal procollagen type III, which is pathognomonic for EDS type IV. The patient and obstetrician preferred a repeat vaginal birth with instrumental delivery in the second stage. Analgesia for labour and delivery was provided with a continuous epidural infusion of ropivacaine and fentanyl. She delivered a healthy female infant with the use of outlet forceps, without complications.
CONCLUSION: A pre-delivery, multidisciplinary, individualized management plan is required in patients with EDS, a rare disease with variable clinical features. In the case described, continuous epidural analgesia was effective and associated with excellent maternal and fetal outcomes.

Entities:  

Mesh:

Year:  2002        PMID: 11983666     DOI: 10.1007/BF03017928

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  2 in total

1.  Ehlers-danlos syndrome in orthopaedics: etiology, diagnosis, and treatment implications.

Authors:  Eric D Shirley; Marlene Demaio; Joanne Bodurtha
Journal:  Sports Health       Date:  2012-09       Impact factor: 3.843

2.  Spinal Anaesthesia for Cesarean Section in a Patient with Vascular Type Ehlers-Danlos Syndrome.

Authors:  Jeffrey M Carness; Mark J Lenart
Journal:  Case Rep Anesthesiol       Date:  2018-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.